One of the largest but least-well-known of the few woman-owned hedge fund firms is the latest life sciences specialist to see big rewards from the red-hot IPO market.
Cormorant Asset Management, headed by Bihua Chen, owns nearly 1.5 million shares of BioAtla, which surged more than 72 percent on its first day of trading on Wednesday, to close at $31.02.
